Chargement en cours...
Cancer Risk after Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy
BACKGROUND AND OBJECTIVES: Cyclophosphamide treatment improves renal survival in patients with idiopathic membranous nephropathy. However, use of cyclophosphamide is associated with cancer. The incidence of malignancies in patients with idiopathic membranous nephropathy was evaluated, and the cancer...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Nephrology
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4046727/ https://ncbi.nlm.nih.gov/pubmed/24855280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.08880813 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|